Literature DB >> 33534227

Outcomes of a Multicenter Training Program in Robotic Pancreatoduodenectomy (LAELAPS-3).

Maurice J W Zwart1, Carolijn L M Nota, Thijs de Rooij, Jony van Hilst, Wouter W Te Riele, Hjalmar C van Santvoort, Jeroen Hagendoorn, Inne H M Borel Rinkes, Jacob L van Dam, Anouk E J Latenstein, Kosei Takagi, T C Khé Tran, Jennifer Schreinemakers, George van der Schelling, Jan H Wijsman, Sebastiaan Festen, Freek Daams, Misha D Luyer, Ignace H J T de Hingh, J Sven D Mieog, Bert A Bonsing, Daan J Lips, Mohammed Abu Hilal, Olivier R Busch, Olivier Saint-Marc, Herbert J Zeh, Amer H Zureikat, Melissa E Hogg, I Quintus Molenaar, Marc G Besselink, Bas Groot Koerkamp.   

Abstract

OBJECTIVE: To assess feasibility and safety of a multicenter training program in robotic pancreatoduodenectomy (RPD) adhering to the IDEAL framework for implementation of surgical innovation.
BACKGROUND: Good results for RPD have been reported from single center studies. However, data on feasibility and safety of implementation through a multicenter training program in RPD are lacking.
METHODS: A multicenter training program in RPD was designed together with the University of Pittsburgh Medical Center, including an online video bank, robot simulation exercises, biotissue drills, and on-site proctoring. Benchmark patients were based on the criteria of Clavien. Outcomes were collected prospectively (March 2016-October 2019). Cumulative sum (CUSUM) analysis of operative time was performed to distinguish the first and second phase of the learning curve. Outcomes were compared between both phases of the learning curve. Trends in nationwide use of robotic and laparoscopic PD were assessed in the Dutch Pancreatic Cancer Audit.
RESULTS: Overall, 275 RPD procedures were performed in seven centers by 15 trained surgeons. The recent benchmark criteria for low-risk PD were met by 125 (45.5%) patients. The conversion rate was 6.5% (n = 18) and median blood loss 250 ml (IQR 150-500). The rate of Clavien-Dindo grade ≥III complications was 44.4% (n = 122), postoperative pancreatic fistula (grade B/C) rate 23.6% (n = 65), 90-day complication-related mortality 2.5% (n = 7) and 90-day cancer-related mortality 2.2.% (n = 6). Median postoperative hospital stay was 12 days (IQR 8-20). In the subgroup of patients with pancreatic cancer (n = 80), the major complication rate was 31.3% and POPF rate was 10%. CUSUM analysis for operative time found a learning curve inflection point at 22 RPDs (IQR 10-35) with similar rates of Clavien-Dindo grade ≥III complications in the first and second phase (43.4% vs 43.8%, P = 0.956, respectively). During the study period the nationwide use of laparoscopic PD reduced from 15% to 1%, whereas the use of RPD increased from 0% to 25%.
CONCLUSIONS: This multicenter RPD training program in centers with sufficient surgical volume was found to be feasible without a negative impact of the learning curve on clinical outcomes.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33534227     DOI: 10.1097/SLA.0000000000004783

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  ASO Author Reflections: The Role of the Robot in Pancreatoduodenectomy.

Authors:  Marcel Autran C Machado; Fabio F Makdissi
Journal:  Ann Surg Oncol       Date:  2021-04-01       Impact factor: 5.344

2.  More is More? Total Pancreatectomy for Periampullary Cancer as an Alternative in Patients with High-Risk Pancreatic Anastomosis: A Propensity Score-Matched Analysis.

Authors:  Anna Burelli; Giampaolo Perri; Giovanni Marchegiani
Journal:  Ann Surg Oncol       Date:  2022-03-19       Impact factor: 5.344

3.  Feasibility of "cold" triangle robotic pancreatoduodenectomy.

Authors:  Emanuele F Kauffmann; Niccolò Napoli; Michael Ginesini; Cesare Gianfaldoni; Fabio Asta; Alice Salamone; Gabriella Amorese; Fabio Vistoli; Ugo Boggi
Journal:  Surg Endosc       Date:  2022-07-26       Impact factor: 3.453

4.  Performance with robotic surgery versus 3D- and 2D-laparoscopy during pancreatic and biliary anastomoses in a biotissue model: pooled analysis of two randomized trials.

Authors:  Maurice J W Zwart; Leia R Jones; Ignacio Fuente; Alberto Balduzzi; Kosei Takagi; Stephanie Novak; Luna A Stibbe; Thijs de Rooij; Jony van Hilst; L Bengt van Rijssen; Susan van Dieren; Aude Vanlander; Peter B van den Boezem; Freek Daams; J Sven D Mieog; Bert A Bonsing; Camiel Rosman; Sebastiaan Festen; Misha D Luyer; Daan J Lips; Arthur J Moser; Olivier R Busch; Mohammad Abu Hilal; Melissa E Hogg; Martijn W J Stommel; Marc G Besselink
Journal:  Surg Endosc       Date:  2021-11-19       Impact factor: 3.453

Review 5.  What Is the Current Role and What Are the Prospects of the Robotic Approach in Liver Surgery?

Authors:  Emre Bozkurt; Jasper P Sijberden; Mohammed Abu Hilal
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

6.  Learning curves in minimally invasive pancreatic surgery: a systematic review.

Authors:  Gayle Fung; Menazir Sha; Basir Kunduzi; Farid Froghi; Saad Rehman; Saied Froghi
Journal:  Langenbecks Arch Surg       Date:  2022-03-12       Impact factor: 2.895

Review 7.  [Surgery for periampullary pancreatic cancer].

Authors:  Thomas Hank; Ulla Klaiber; Klaus Sahora; Martin Schindl; Oliver Strobel
Journal:  Chirurg       Date:  2021-07-14       Impact factor: 0.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.